Literature DB >> 16829754

Colposcopy services in the United Arab Emirates.

Saad Ghazal-Aswad1, Padmanabhan Badrinath, Islam Sidky, Husnia Gargash.   

Abstract

BACKGROUND: United Arab Emirates (UAE) is a young country with a population of 3 million, an abundant oil wealth, and a high standard of living. There is no organized cervical screening program, but the authorities are planning to introduce one soon.
OBJECTIVE: To study the availability and quality of colposcopy services.
METHODS: A questionnaire survey of all gynecologists in the major government and private hospitals in the country.
RESULTS: Twenty government hospitals offer obstetrics and gynecology services, 11 governments and 4 private hospitals have colposcopy services. Of the 52 specialists performing colposcopy, 8 had adequate training, 3 had formal recognition, and 3 had long-term experience. The number of cases seen per doctor varies from 10 to 100 a year, with a mean and median of 28 and 15, respectively. Three units had the required basic colposcopy equipment for diagnosis and treatment. Only 1 unit performs audit.
CONCLUSIONS: Colposcopy service is widely available in many hospitals in the United Arab Emirates, but substantial variation exists in clinical standards and needs more organization and standardization.

Entities:  

Mesh:

Year:  2006        PMID: 16829754     DOI: 10.1097/00128360-200607000-00006

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  2 in total

1.  Frequency of rare and multi viral high-risk HPV types infection in cervical high grade squamous intraepithelial lesions in a non-native dominant middle eastern country: a polymerase chain reaction-based pilot study.

Authors:  Alia Albawardi; M Ruhul Quddus; Shamsa Al Awar; Saeeda Almarzooqi
Journal:  Diagn Pathol       Date:  2018-06-26       Impact factor: 2.644

2.  Perspectives on cervical cancer screening among educated Muslim women in Dubai (the UAE): a qualitative study.

Authors:  Sarah Khan; Gillian Woolhead
Journal:  BMC Womens Health       Date:  2015-10-24       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.